Latest Releases

Researchers at Northwestern have developed a new platform that could produce new covid-19 therapeutics more than 10 times faster than current methods.

As the U.S. battles to gain more access to COVID-19 swabs and testing kits, the next step will be to determine who has developed immunity to the virus, and that will be done through serology testing.
* Media Advisory

Northwestern University is launching a series of virtual roundtables with industry leaders representing the transportation, logistics and supply chain industries who are coping with COVID-19.

By analyzing movie data from 1910 to 2010, researchers found that female representation in the film industry hit an all-time low during the Golden Age of Hollywood.

Northwestern Medicine has enrolled its first participants in a new clinical drug trial for COVID-19. The drug being tested is a novel anti-viral drug developed to treat Ebola and which has been found to have antiviral activity against coronaviruses.

A new smartphone app is helping parents ease the stress of parenting a baby in the NICU, especially during the extremely limited visitation parents are experiencing during the COVID-19 outbreak.

Northwestern University has received the U.S. EPA’s 2020 ENERGY STAR® Partner of the Year - Sustained Excellence Award for continued leadership in energy efficiency and energy conservation solutions.

Since last week, the Office of Research Safety at Northwestern University has delivered urgent medical supplies collected from campus labs and researchers for use by healthcare workers at Northwestern Memorial Hospital (NMH).

Northwestern University Feinberg School of Medicine has established a special COVID-19 testing team with the goal of at least quadrupling the number of tests processed.
* Media Advisory

Researchers are using high-area rapid printing (HARP) -- a 3D printing technique with record-throughput -- to print personal protective equipment (PPE) for health care workers.